Koninklijke Philips NV ADR (PHG) Shares Outstanding 2006–TTM

Name: Koninklijke Philips NV ADR (PHG) shares outstanding history 2006-TTM
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-09-19

Koninklijke Philips NV ADR annual shares outstanding for fiscal 2025 was 963 million shares, an increase of 3.2% from 933 million shares in fiscal 2024. All figures are reported results from public filings — no estimates or projections.

PHG Annual Shares Outstanding

Shares Outstanding (annual)	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Shares Outstanding (M)	—	963M	933M	949M	952M	950M	958M	973M	997M	1,007M	990M	984M	983M	983M	988M	1,020M	1,010M	990M	1,062M	1,170M	1,261M

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

PHG Quarterly Shares Outstanding

Shares Outstanding (quarterly)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Shares Outstanding (M)	—	969M	966M	964M	957M	938M	929M	913M	942M

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Shares Outstanding at Comparable Companies

PEN Shares Outstanding — Penumbra Inc
SNN Shares Outstanding — Smith & Nephew SNATS Inc
BIO Shares Outstanding — Bio-Rad Laboratories Inc
GMED Shares Outstanding — Globus Medical
BIO.B Shares Outstanding — Bio-Rad Laboratories Inc
GKOS Shares Outstanding — Glaukos Corp

More PHG metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · EBITDA · Free Cash Flow

All PHG financial statements → Interactive PHG charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.